LifeMD, Inc. (LFMD)

Market Cap	304.89M
Revenue (ttm)	245.56M
Net Income (ttm)	-9.03M
Shares Out	47.42M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,063,020
Open	6.21
Previous Close	6.22
Day's Range	6.18 - 6.57
52-Week Range	3.99 - 15.84
Beta	1.57
Analysts	Buy
Price Target	12.50 (+94.4%)
Earnings Date	Nov 6, 2025

About LFMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications,...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1994
• Employees: 307
• Stock Exchange: NASDAQ
• Ticker Symbol: LFMD
• Website: https://lifemd.com

Financial Performance

In 2024, LifeMD's revenue was $212.45 million, an increase of 39.27% compared to the previous year's $152.55 million. Losses were -$21.99 million, -7.23% less than in 2023.

Analyst Forecast

According to 6 analysts, the average rating for LFMD stock is "Buy." The 12-month stock price target is $12.5, which is an increase of 94.40% from the latest price.

Price Target

$12.5

(94.40% upside)

Analyst Consensus: Buy